Your browser doesn't support javascript.
loading
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies.
Heinemann, Fabian; Gross, Peter; Zeveleva, Svetlana; Qian, Hu Sheng; Hill, Jon; Höfer, Anne; Jonigk, Danny; Diehl, Anna Mae; Abdelmalek, Manal; Lenter, Martin C; Pullen, Steven S; Guarnieri, Paolo; Stierstorfer, Birgit.
Afiliação
  • Heinemann F; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riß, Germany. fabian.heinemann@boehringer-ingelheim.com.
  • Gross P; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riß, Germany.
  • Zeveleva S; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Qian HS; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Hill J; Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Höfer A; Institute of Pathology, Hannover Medical School, and the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 30625, Hanover, Germany.
  • Jonigk D; Institute of Pathology, Hannover Medical School, and the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 30625, Hanover, Germany.
  • Diehl AM; Duke Department of Medicine, Gastroenterology, Lasalle Street, GSRB 1, Durham, NC, 27710, USA.
  • Abdelmalek M; Duke Department of Medicine, Gastroenterology, Lasalle Street, GSRB 1, Durham, NC, 27710, USA.
  • Lenter MC; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riß, Germany.
  • Pullen SS; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Guarnieri P; Cardiometabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Stierstorfer B; Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riß, Germany.
Sci Rep ; 12(1): 19236, 2022 11 10.
Article em En | MEDLINE | ID: mdl-36357500

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Aprendizado Profundo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Aprendizado Profundo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha